SCHEMBL31210747

SCHEMBL31210747

COC(=O)c1ccc(N2CCN(C(=O)OC(C)(C)C)CC2)c2cc[nH]c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GOT1 P17174 2/20 0.46
▸ NR1H2 P55055 1/20 0.43
▸ BACE1 P56817 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ JAK1 P23458 3/20 0.41
▸ JAK2 O60674 1/20 0.41
▸ TYK2 P29597 1/20 0.41
▸ JAK3 P52333 1/20 0.41
▸ BTK Q06187 2/20 0.40
▸ KIT P10721 1/20 0.40
▸ EED O75530 1/20 0.39
▸ RBBP4 Q09028 1/20 0.39
▸ SUZ12 Q15022 1/20 0.39
▸ EZH2 Q15910 1/20 0.39
▸ AEBP2 Q6ZN18 1/20 0.39
▸ NAMPT P43490 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ BRD4 O60885 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31210541 0.89 GOT1 (0.47) GOT1BACE1ALDH1A1LMNAMAPT
SCHEMBL5704985 0.84 GOT1 (0.45) GOT1BACE1ALDH1A1LMNAMAPT
SCHEMBL5704854 0.83 MAPT (0.46) GOT1BACE1ALDH1A1LMNAMAPT
SCHEMBL5704915 0.83 DRD2 (0.50) GOT1BACE1ALDH1A1LMNAMAPT
SCHEMBL25102966 0.79 NR1H2 (0.42) NR1H2BACE1ALDH1A1LMNAMAPT
SCHEMBL25337613 0.78 BACE1 (0.44) GOT1BACE1ALDH1A1LMNAMAPT
SCHEMBL16336702 0.78 JAK1 (0.49) ALDH1A1MAPTJAK1JAK2TYK2
SCHEMBL3723331 0.78 JAK1 (0.51) NR1H2ALDH1A1MAPTJAK1JAK2
SCHEMBL31211125 0.77 BTK (0.39) GOT1ALDH1A1LMNAMAPTJAK1
SCHEMBL2428090 0.77 PIM3 (0.47) ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024182778-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING REMIX THERAPEUTICS INC. (US) 2024-09-06 — — WO disclosed
Send feedback